CIL-102 is a semisynthetic alkaloid derivative, which inhibits cell growth in a wide variety of cancer cell lines in a dose dependent manner. Studies conducted with Immunofluorescence microscopy suggest that CIL-102 can functions to slow down cell growth by binding to Tubulin, inhibiting Tubulin polymerization and disrupting microtubule organization. In addition, cells accumulate in the presence of CIL-102 in G(2)/M phase and sub-G(0)/G(1) phase. CIL-102 causes apoptosis in PC-3 cells via activation of caspase-3 and slows down cell growth by modulating cyclin-dependent kinases.
Test | Specification | Results |
---|---|---|
Appearance | Yellow solid | |
Identification (1H-NMR) | Consistent with structure | |
Purity (HPLC) | 97.6% | |
Molecular Weight | Complies (by Mass spectrometry) | |
Solubility | Clear solution at 12 mg/ml in dimethyl sulfoxide | |
Carbon Content | 73.58% | |
Hydrogen Content | 4.60% | |
Nitrogen Content | 9.01% | |
Water Content (CHN) | 0.5 mole/mole |
Exp. Date: 11/13/2023